Literature DB >> 23548614

Longer T(2) relaxation time is a marker of hypothalamic gliosis in mice with diet-induced obesity.

Donghoon Lee1, Joshua P Thaler, Kathryn E Berkseth, Susan J Melhorn, Michael W Schwartz, Ellen A Schur.   

Abstract

A hallmark of brain injury from infection, vascular, neurodegenerative, and other disorders is the development of gliosis, which can be detected by magnetic resonance imaging (MRI). In rodent models of diet-induced obesity (DIO), high-fat diet (HFD) consumption rapidly induces inflammation and gliosis in energy-regulating regions of the mediobasal hypothalamus (MBH), and recently we reported MRI findings suggestive of MBH gliosis in obese humans. Thus, noninvasive imaging may obviate the need to assess MBH gliosis using histopathological end points, an obvious limitation to human studies. To investigate whether quantitative MRI is a valid tool with which to measure MBH gliosis, we performed analyses, including measurement of T(2) relaxation time from high-field MR brain imaging of mice fed HFD and chow-fed controls. Mean bilateral T(2) relaxation time was prolonged significantly in the MBH, but not in the thalamus or cortex, of HFD-fed mice compared with chow-fed controls. Histological analysis confirmed evidence of increased astrocytosis and microglial accumulation in the MBH of HFD-fed mice compared with controls, and T(2) relaxation times in the right MBH correlated positively with mean intensity of glial fibrillary acidic protein staining (a marker of astrocytes) in HFD-fed animals. Our findings indicate that T(2) relaxation time obtained from high-field MRI is a useful noninvasive measurement of HFD-induced gliosis in the mouse hypothalamus with potential for translation to human studies.

Entities:  

Keywords:  gliosis; high-fat diet; hypothalamus; magnetic resonance imaging; obesity

Mesh:

Substances:

Year:  2013        PMID: 23548614      PMCID: PMC3680680          DOI: 10.1152/ajpendo.00020.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  24 in total

1.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI.

Authors:  P J Basser; C Pierpaoli
Journal:  J Magn Reson B       Date:  1996-06

2.  Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity.

Authors:  Tamas L Horvath; Beatrix Sarman; Cristina García-Cáceres; Pablo J Enriori; Peter Sotonyi; Marya Shanabrough; Erzsebet Borok; Jesus Argente; Julie A Chowen; Diego Perez-Tilve; Paul T Pfluger; Hella S Brönneke; Barry E Levin; Sabrina Diano; Michael A Cowley; Matthias H Tschöp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry.

Authors:  G D Jackson; A Connelly; J S Duncan; R A Grünewald; D G Gadian
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

4.  Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

Authors:  J C Vernant; P Cabre; D Smadja; H Merle; I Caubarrère; J Mikol; C M Poser
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

5.  Exercise protects against high-fat diet-induced hypothalamic inflammation.

Authors:  Chun-Xia Yi; Omar Al-Massadi; Elizabeth Donelan; Maarit Lehti; Jon Weber; Chandler Ress; Chitrang Trivedi; Timo D Müller; Stephen C Woods; Susanna M Hofmann
Journal:  Physiol Behav       Date:  2012-03-29

6.  Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging.

Authors:  G D Jackson; S R Williams; R O Weller; N van Bruggen; N E Preece; S C Williams; W H Butler; J S Duncan
Journal:  Epilepsy Res       Date:  1994-05       Impact factor: 3.045

7.  Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis.

Authors:  Frank C Tinsley; Gersh Z Taicher; Mark L Heiman
Journal:  Obes Res       Date:  2004-01

8.  Reversible MRI changes of hypothalamus in a multiple sclerosis patient with homeostatic disturbances.

Authors:  E Y K Tsui; S F Yip; S H Ng; Y K Cheung
Journal:  Eur Radiol       Date:  2002-05-16       Impact factor: 5.315

9.  High-fat-diet exposure induces IgG accumulation in hypothalamic microglia.

Authors:  Chun-Xia Yi; Matthias H Tschöp; Stephen C Woods; Susanna M Hofmann
Journal:  Dis Model Mech       Date:  2012-03-01       Impact factor: 5.758

10.  Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases.

Authors:  Y L Chung; A Williams; D Ritchie; S C Williams; K K Changani; J Hope; J D Bell
Journal:  Neuroreport       Date:  1999-11-26       Impact factor: 1.837

View more
  22 in total

1.  Initial evidence for hypothalamic gliosis in children with obesity by quantitative T2 MRI and implications for blood oxygen-level dependent response to glucose ingestion.

Authors:  Leticia E Sewaybricker; Ellen A Schur; Susan J Melhorn; Brunno M Campos; Mary K Askren; Guilherme A S Nogueira; Mariana P Zambon; Maria Angela R G M Antonio; Fernando Cendes; Licio A Velloso; Gil Guerra-Junior
Journal:  Pediatr Obes       Date:  2018-12-10       Impact factor: 4.000

2.  Roux-en-Y gastric bypass surgery progressively alters radiologic measures of hypothalamic inflammation in obese patients.

Authors:  Mohammed K Hankir; Michael Rullmann; Florian Seyfried; Sven Preusser; Sindy Poppitz; Stefanie Heba; Konstantinos Gousias; Jana Hoyer; Tatjana Schütz; Arne Dietrich; Karsten Müller; Burkhard Pleger
Journal:  JCI Insight       Date:  2019-10-03

Review 3.  Glia: silent partners in energy homeostasis and obesity pathogenesis.

Authors:  John D Douglass; Mauricio D Dorfman; Joshua P Thaler
Journal:  Diabetologia       Date:  2016-12-16       Impact factor: 10.122

4.  Associations Between Body Weight, Hippocampal Volume, and Tissue Signal Intensity in 12- to 18-Year-Olds.

Authors:  Zoe Mestre; Amanda Bischoff-Grethe; Christina E Wierenga; Terry Jernigan; Dawn M Eichen; Linda Chang; Thomas Ernst; Kerri N Boutelle
Journal:  Obesity (Silver Spring)       Date:  2020-06-05       Impact factor: 5.002

5.  Magnetic resonance assessment of the cerebral alterations associated with obesity development.

Authors:  Blanca Lizarbe; Basilio Campillo; Irene Guadilla; Pilar López-Larrubia; Sebastián Cerdán
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-23       Impact factor: 6.200

6.  Hypothalamic Inflammation: Is There Evidence for Human Obesity?

Authors:  Rekha B Kumar; Louis J Aronne
Journal:  Curr Obes Rep       Date:  2014-06

7.  Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.

Authors:  Eugenia Morselli; Esther Fuente-Martin; Brian Finan; Min Kim; Aaron Frank; Cristina Garcia-Caceres; Carlos Rodriguez Navas; Ruth Gordillo; Michael Neinast; Sarada P Kalainayakan; Dan L Li; Yuanqing Gao; Chun-Xia Yi; Lisa Hahner; Biff F Palmer; Matthias H Tschöp; Deborah J Clegg
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

8.  Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance.

Authors:  J M Moreno-Navarrete; G Blasco; J Puig; C Biarnés; M Rivero; J Gich; F Fernández-Aranda; J Garre-Olmo; L Ramió-Torrentà; Á Alberich-Bayarri; F García-Castro; S Pedraza; W Ricart; J M Fernández-Real
Journal:  Int J Obes (Lond)       Date:  2017-07-07       Impact factor: 5.095

9.  Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study.

Authors:  Kathryn E Berkseth; Stephan J Guyenet; Susan J Melhorn; Donghoon Lee; Joshua P Thaler; Ellen A Schur; Michael W Schwartz
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

Review 10.  Craniopharyngioma adherence: a reappraisal of the evidence.

Authors:  Ruth Prieto; José María Pascual; Verena Hofecker; Eduard Winter; Inés Castro-Dufourny; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2018-07-24       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.